Grifols Financial Statements From 2010 to 2025
| GRFS Stock | USD 8.10 0.12 1.50% |
Check Grifols SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Grifols SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Grifols financial statements analysis is a perfect complement when working with Grifols SA Valuation or Volatility modules.
Grifols |
Grifols SA ADR Company Profit Margin Analysis
Grifols SA's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Grifols SA Profit Margin | 0.02 % |
Most of Grifols SA's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grifols SA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Grifols SA ADR has a Profit Margin of 0.0231%. This is 100.21% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The profit margin for all United States stocks is 101.82% lower than that of the firm.
Grifols SA ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grifols SA's current stock value. Our valuation model uses many indicators to compare Grifols SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grifols SA competition to find correlations between indicators driving Grifols SA's intrinsic value. More Info.Grifols SA ADR is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 1.06 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all technique that is used if you cannot value Grifols SA by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Grifols SA Financial Statements
Grifols SA shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Grifols SA investors may analyze each financial statement separately, they are all interrelated. The changes in Grifols SA's assets and liabilities, for example, are also reflected in the revenues and expenses on on Grifols SA's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols SA operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 27584 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Grifols Stock Analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.